GHK-Cu and TB-500 (often discussed in research literature in relation to thymosin-beta-4 fragments) are different materials with different documentation needs. Research buyers should not treat them as drop-in substitutes.
Start with the protocol name
Order the compound named in your method, ethics approval, or experimental plan. Catalogue proximity and similar “research peptide” labelling are not scientific equivalence.
Documentation to request or review
- Lot ID matching the COA
- Identity and purity methods stated
- Clear labelled amount and presentation
- Dispatch and packaging notes when storage is constrained
Combination products
Where TB-500 appears inside a blend listing, confirm whether published testing covers the finished combination lot or only a related single-compound intermediate.